Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO2022008760 - METHOD FOR CLASSIFYING A SUBJECT SUSPECTED TO SUFFER FROM AN ACUTE EVENT IN A RISK GROUP

Publication Number WO/2022/008760
Publication Date 13.01.2022
International Application No. PCT/EP2021/069367
International Filing Date 12.07.2021
IPC
G01N 33/53 2006.1
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
Applicants
  • SORBONNE UNIVERSITÉ [FR]/[FR]
  • INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) [FR]/[FR]
Inventors
  • SAUCE, Delphine
  • LARSEN, Martin
Agents
  • ICOSA
Priority Data
20305794.810.07.2020EP
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) METHOD FOR CLASSIFYING A SUBJECT SUSPECTED TO SUFFER FROM AN ACUTE EVENT IN A RISK GROUP
(FR) PROCÉDÉ DE CLASSIFICATION D’UN SUJET SUSCEPTIBLE D’ÊTRE ATTEINT D’UN ÉVÉNEMENT AIGU DANS UN GROUPE DE RISQUE
Abstract
(EN) The present invention relates to an in vitro method of classifying a subject suspected to suffer from an acute event comprising the steps of determining neopterin concentration in a biological sample obtained from said subject; comparing said concentration with a predetermined reference neopterin concentration, and assigning the subject to a risk group based on the comparison of the neopterin concentration with the predetermined reference neopterin concentration.
(FR) La présente invention concerne un procédé in vitro de classification d’un sujet susceptible d’être atteint d’un événement aigu, comprenant les étapes consistant à déterminer la concentration en néoptérine dans un échantillon biologique obtenu sur ledit sujet ; comparer ladite concentration à une concentration de néoptérine de référence prédéterminée, et affecter le sujet à un groupe de risque d’après la comparaison de la concentration en néoptérine à la concentration de néoptérine de référence prédéterminée.
Latest bibliographic data on file with the International Bureau